NANKI T[au] - Search Results

Year	Number of Results
1993	1
1994	2
1995	1
1996	3
1997	3
1998	3
1999	2
2000	4
2001	5
2002	4
2003	1
2004	4
2005	9
2006	2
2007	5
2008	6
2009	11
2010	3
2011	7
2012	9
2013	8
2014	11
2015	7
2016	10
2017	8
2018	6
2019	6
2020	8
2021	14
2022	4

1

Fractalkine/CX3CL1 in rheumatoid arthritis.

Nanki T, Imai T, Kawai S. Nanki T, et al. Mod Rheumatol. 2017 May;27(3):392-397. doi: 10.1080/14397595.2016.1213481. Epub 2016 Aug 2. Mod Rheumatol. 2017. PMID: 27484962 Free article. Review.

2

Treatment of Refractory RS3PE Syndrome With Tocilizumab.

Sato H, Yamada S, Muraoka S, Masuoka S, Kawazoe M, Nanki T. Sato H, et al. Among authors: nanki t. J Clin Rheumatol. 2021 Dec 1;27(8S):S814. doi: 10.1097/RHU.0000000000001451. J Clin Rheumatol. 2021. PMID: 35073642 No abstract available.

3

Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists.

Kawazoe M, Kihara M, Nanki T. Kawazoe M, et al. Among authors: nanki t. Pharmaceuticals (Basel). 2021 Dec 2;14(12):1256. doi: 10.3390/ph14121256. Pharmaceuticals (Basel). 2021. PMID: 34959657 Free PMC article. Review.

4

[Fractalkine and inflammatory diseases].

Imai T, Nishimura M, Nanki T, Umehara H. Imai T, et al. Among authors: nanki t. Nihon Rinsho Meneki Gakkai Kaishi. 2005 Jun;28(3):131-9. doi: 10.2177/jsci.28.131. Nihon Rinsho Meneki Gakkai Kaishi. 2005. PMID: 15997176 Free article. Review. Japanese.

5

[Treatment for rheumatoid arthritis by chemokine blockade].

Nanki T. Nanki T. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):172-80. doi: 10.2177/jsci.39.172. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27320932 Free article. Review. Japanese.

6

Could retinoids be a potential treatment for rheumatic diseases?

Miyabe Y, Miyabe C, Nanki T. Miyabe Y, et al. Among authors: nanki t. Rheumatol Int. 2015 Jan;35(1):35-41. doi: 10.1007/s00296-014-3067-2. Epub 2014 Jun 18. Rheumatol Int. 2015. PMID: 24939557 Review.

7

Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases.

Muraoka S, Nishio J, Kuboi Y, Imai T, Nanki T. Muraoka S, et al. Among authors: nanki t. Expert Opin Biol Ther. 2020 Nov;20(11):1309-1319. doi: 10.1080/14712598.2020.1764931. Epub 2020 May 13. Expert Opin Biol Ther. 2020. PMID: 32401060 Review.

8

[Essential thrombocythemia in pregnancy].

Tomiyama J, Komeno T, Nanki T, Kaneko H, Kudo H, Teratani T, Moriya K. Tomiyama J, et al. Among authors: nanki t. Rinsho Ketsueki. 1993 Dec;34(12):1579-83. Rinsho Ketsueki. 1993. PMID: 8295333 Review. Japanese.

9

COVID-19 in a Patient With Rheumatoid Arthritis During Tocilizumab Treatment.

Yamada Z, Nanki T. Yamada Z, et al. Among authors: nanki t. J Clin Rheumatol. 2020 Sep;26(6):240-241. doi: 10.1097/RHU.0000000000001576. J Clin Rheumatol. 2020. PMID: 32732527 Free PMC article. No abstract available.

10

Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis.

Mizutani S, Kodera H, Sato Y, Nanki T, Yoshida S, Yasuoka H. Mizutani S, et al. Among authors: nanki t. Clin Rheumatol. 2021 Jan;40(1):123-132. doi: 10.1007/s10067-020-05208-y. Epub 2020 Jun 6. Clin Rheumatol. 2021. PMID: 32506311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results